JP2024509273A5 - - Google Patents

Info

Publication number
JP2024509273A5
JP2024509273A5 JP2023555307A JP2023555307A JP2024509273A5 JP 2024509273 A5 JP2024509273 A5 JP 2024509273A5 JP 2023555307 A JP2023555307 A JP 2023555307A JP 2023555307 A JP2023555307 A JP 2023555307A JP 2024509273 A5 JP2024509273 A5 JP 2024509273A5
Authority
JP
Japan
Prior art keywords
group
tme
hla
signature
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024509273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019538 external-priority patent/WO2022192393A1/en
Publication of JP2024509273A publication Critical patent/JP2024509273A/ja
Publication of JP2024509273A5 publication Critical patent/JP2024509273A5/ja
Pending legal-status Critical Current

Links

JP2023555307A 2021-03-09 2022-03-09 Ｂ細胞に富む腫瘍微小環境 Pending JP2024509273A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163158816P 2021-03-09 2021-03-09
US63/158,816 2021-03-09
PCT/US2022/019538 WO2022192393A1 (en) 2021-03-09 2022-03-09 B cell-enriched tumor microenvironments

Publications (2)

Publication Number Publication Date
JP2024509273A JP2024509273A (ja) 2024-02-29
JP2024509273A5 true JP2024509273A5 (https=) 2025-03-07

Family

ID=80930177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555307A Pending JP2024509273A (ja) 2021-03-09 2022-03-09 Ｂ細胞に富む腫瘍微小環境

Country Status (5)

Country Link
US (1) US20220307088A1 (https=)
EP (1) EP4305208A1 (https=)
JP (1) JP2024509273A (https=)
CA (1) CA3213109A1 (https=)
WO (1) WO2022192393A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240177803A1 (en) 2022-11-17 2024-05-30 Bostongene Corporation Comprehensive immunoprofiling of peripheral blood
EP4695425A1 (en) * 2023-04-13 2026-02-18 BostonGene Corporation Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202209539D0 (en) 2017-06-13 2022-08-10 Bostongene Corp Systems and methods for identifying cancer treatments from normalized biomarker scores
CN112133365B (zh) * 2020-09-03 2022-05-10 南方医科大学南方医院 评估肿瘤微环境的基因集、评分模型及其应用

Similar Documents

Publication Publication Date Title
EP3695408B1 (en) Medical use of cdk4/6- and checkpoint-inhibitors in phased combination, in treatment of cancer
US20200157633A1 (en) Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer
US20240282449A1 (en) Methods and systems for machine learning analysis of inflammatory skin diseases
JP2024509576A5 (https=)
Ren et al. Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance
CA2537254A1 (en) Methods for identifying, diagnosing, and predicting survival of lymphomas
US20230340601A1 (en) Transcriptome Analysis For Treating Inflammation
US20230073731A1 (en) Gene expression analysis techniques using gene ranking and statistical models for identifying biological sample characteristics
US20250270640A1 (en) Antigen reactive t-cell receptors
JP2024509273A5 (https=)
US20240254565A1 (en) Unique cancer associated fibroblast subsets predict response to immunotherapy
JP2024541909A5 (https=)
JP2024512426A5 (https=)
US20220307088A1 (en) B cell-enriched tumor microenvironments
CN118692700B (zh) Pd-l1抑制剂靶向治疗预后预测模型及构建方法
JP2022061491A (ja) 慢性副鼻腔炎の患者を分類するためのデータの取得方法、およびその利用
US20220290254A1 (en) B cell-enriched tumor microenvironments
WO2024025923A1 (en) Methods for selection of cancer patients for anti-angiogenic and immune checkpoint blockade therapies and combinations thereof
Rim et al. Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk
Pushparaj Translational interest of immune profiling
US20260031182A1 (en) Method to determine a predominant immune signal in a breast cancer microenvironment
EP2922971B1 (en) Gene expression profile in diagnostics
US20260117297A1 (en) Longitudinal Gene Expression Analysis of Inflammatory Skin Diseases
Garg Prognostic biomarker discovery from omics data using machine learning approaches
US20230125549A1 (en) Methods and compositions for assessing immune response in murine tumor models